Lowering Your Chemical Load — Without Losing Your Mind
“The goal of this book isn’t to be perfect; it’s to be as healthy as possible without losing your mind, your money, or your sense of well-being.”
“The goal of this book isn’t to be perfect; it’s to be as healthy as possible without losing your mind, your money, or your sense of well-being.”
AbstractThe development of novel treatments has improved cancer outcomes but may result in cardiovascular toxicities. Traditional approaches to clinical trial safety evaluation have limitations in…
Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston,…
AbstractDrug-coated balloons (DCBs) provide a stent-free alternative, reducing risks like stent thrombosis and in-stent restenosis and the need for prolonged dual antiplatelet therapy. Recent studi…
A study of real-world data found that tolvaptan reduced long-term kidney function decline in autosomal dominant polycystic kidney disease (ADPKD) but did not affect kidney…
AbstractCoarctation of aorta (CoA) in adults is often diagnosed incidentally during the work-up for secondary or resistant hypertension causes, making it one of the treatable…
Highlights •MI initiates a robust angiogenic response crucial for tissue repair. This study demonstrates a new perspective on the mechanism of the BHB–epigenetic landscape–EC homeostasis…
Alex McDonald, MD, and Barry K. Herman, MD, offer resources to help primary care physicians become more comfortable with diagnosing and managing ADHD.
Azacitidine plus valproic acid is a safe and feasible maintenance regimen for patients with high-risk AML and MDS following HSCT.
Air travel can be safe and fun, but not all aspects of it are good for you. Doctors have these tips for keeping your time…
Arm D of the SEQUOIA trial evaluated the combo in patients with either del(17p) or TP53 mutation, both mutations, or neither.